J.P. Devissaguet

4.2k total citations · 1 hit paper
40 papers, 3.3k citations indexed

About

J.P. Devissaguet is a scholar working on Pharmaceutical Science, Molecular Biology and Oncology. According to data from OpenAlex, J.P. Devissaguet has authored 40 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmaceutical Science, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in J.P. Devissaguet's work include Advanced Drug Delivery Systems (14 papers), Drug Solubulity and Delivery Systems (8 papers) and Nanoparticle-Based Drug Delivery (6 papers). J.P. Devissaguet is often cited by papers focused on Advanced Drug Delivery Systems (14 papers), Drug Solubulity and Delivery Systems (8 papers) and Nanoparticle-Based Drug Delivery (6 papers). J.P. Devissaguet collaborates with scholars based in France, Spain and Israel. J.P. Devissaguet's co-authors include Hatem Fessi, F. Puisieux, Nazih Ammoury, S. Benita, Christiane Damgé, Marc Aprahamian, Christine Michel, Patrick Couvreur, Gillian Barratt and L. Roblot-Treupel and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and International Journal of Pharmaceutics.

In The Last Decade

J.P. Devissaguet

40 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanocapsule formation by interfacial polymer deposition following solvent displacement

1989 1.8k citations Hatem Fessi, F. Puisieux et al. International Journal of Pharmaceutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.P. Devissaguet France	21	1.3k	1.2k	702	512	496	40	3.3k
S. Benita Israel	15	976 0.7×	1.0k 0.8×	539 0.8×	485 0.9×	364 0.7×	22	2.5k
Yoshiharu Machida Japan	35	2.2k 1.6×	1.3k 1.0×	1.1k 1.6×	467 0.9×	364 0.7×	161	4.2k
J. L. Vila-Jato Spain	21	1.9k 1.5×	1.1k 0.9×	753 1.1×	310 0.6×	334 0.7×	42	3.3k
Abraham Rubinstein Israel	37	1.3k 1.0×	687 0.6×	1.0k 1.4×	338 0.7×	646 1.3×	113	4.4k
Joachim M. Mayer Switzerland	21	840 0.6×	1.3k 1.1×	550 0.8×	657 1.3×	512 1.0×	49	3.8k
Jan Karlsen Norway	26	876 0.7×	641 0.5×	924 1.3×	531 1.0×	457 0.9×	97	3.9k
A. A. Hıncal Türkiye	26	1.3k 1.0×	764 0.6×	551 0.8×	284 0.6×	274 0.6×	77	2.4k
Rachna Kumria India	24	2.0k 1.5×	1.3k 1.0×	475 0.7×	540 1.1×	353 0.7×	37	4.0k
Ming‐Thau Sheu Taiwan	39	1.1k 0.8×	1.2k 0.9×	706 1.0×	748 1.5×	248 0.5×	162	4.2k
Nazih Ammoury France	7	749 0.6×	883 0.7×	406 0.6×	380 0.7×	287 0.6×	7	2.1k

Countries citing papers authored by J.P. Devissaguet

Since Specialization

Citations

This map shows the geographic impact of J.P. Devissaguet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Devissaguet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Devissaguet more than expected).

Fields of papers citing papers by J.P. Devissaguet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.P. Devissaguet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Devissaguet. The network helps show where J.P. Devissaguet may publish in the future.

Co-authorship network of co-authors of J.P. Devissaguet

This figure shows the co-authorship network connecting the top 25 collaborators of J.P. Devissaguet. A scholar is included among the top collaborators of J.P. Devissaguet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.P. Devissaguet. J.P. Devissaguet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Benoit, B., Philippe Legrand, Vanessa Carla Furtado Mosqueira, et al.. (2001). The antileishmanial properties of surface-modified, primaquine-loaded nanocapsules tested against intramacrophagic Leishmania donovani amastigotes in vitro. Annals of Tropical Medicine and Parasitology. 95(5). 529–533. 11 indexed citations

Benoit, B., Philippe Legrand, Vanessa Carla Furtado Mosqueira, et al.. (2001). The antileishmanial properties of surface-modified, primaquine-loaded nanocapsules tested against intramacrophagic Leishmania donovani amastigotes in vitro. Annals of Tropical Medicine and Parasitology. 95(5). 529–533. 10 indexed citations

Guterres, Sı́lvia Stanisçuaski, Hatem Fessi, Gillian Barratt, F. Puisieux, & J.P. Devissaguet. (2000). Poly(rac-lactide) nanocapsules containing diclofenac: protection against muscular damage in rats. Journal of Biomaterials Science Polymer Edition. 11(12). 1347–1355. 12 indexed citations

Passirani, Catherine, et al.. (1999). Preparation and characterization of nanoparticles bearing heparin or dextran covalently-linked to poly(methyl methacrylate). Journal of Biomaterials Science Polymer Edition. 10(1). 47–62. 18 indexed citations

Devissaguet, J.P., et al.. (1999). Pulsed estrogen therapy: pharmacokinetics of intranasal 17-beta-estradiol (S21400) in postmenopausal women and comparison with oral and transdermal formulations. European Journal of Drug Metabolism and Pharmacokinetics. 24(3). 265–271. 65 indexed citations

Fessi, Hatem, et al.. (1997). Influence of sterilization processes on poly(ε-caprolactone) nanospheres. Biomaterials. 18(4). 327–335. 54 indexed citations

Fessi, Hatem, et al.. (1997). Preparation of pseudolatex by nanoprecipitation: Influence of the solvent nature on intrinsic viscosity and interaction constant. International Journal of Pharmaceutics. 146(2). 233–238. 110 indexed citations

Espuelas, Socorro, Philippe Legrand, Juan M. Irache, et al.. (1997). Poly(ε-caprolacton) nanospheres as an alternative way to reduce amphotericin B toxicity. International Journal of Pharmaceutics. 158(1). 19–27. 67 indexed citations

Morin, Christophe, et al.. (1995). Induction of macrophage NO-synthase by an immuno-modulator entrapped within polymeric nanocapsules. European Journal of Pharmaceutics and Biopharmaceutics. 41(1). 49–54. 9 indexed citations

10.

Benoît, Jean‐Pierre, et al.. (1995). Cisplatin-loaded poly (methyl methacrylate) implants: a sustained drug delivery system. Journal of Controlled Release. 33(1). 107–113. 22 indexed citations

11.

Morin, Christophe, Hatem Fessi, J.P. Devissaguet, F. Puisieux, & Gillian Barratt. (1994). Factors influencing macrophage activation by muramyl peptides: inhibition of NO synthase activity by high levels of NO. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1224(3). 427–432. 6 indexed citations

12.

Barratt, Gillian, et al.. (1994). Anti-metastic activity of MDP-L-alanyl-cholesterol incorporated into various types of nanocapsules. International Journal of Immunopharmacology. 16(5-6). 457–461. 20 indexed citations

13.

Morin, Christophe, Gillian Barratt, Hatem Fessi, J.P. Devissaguet, & F. Puisieux. (1994). Improved intracellular delivery of a muramyl dipeptide analog by means of nanocapsules. International Journal of Immunopharmacology. 16(5-6). 451–456. 12 indexed citations

14.

Morin, Christophe, Gillian Barratt, Hatem Fessi, J.P. Devissaguet, & F. Puisieux. (1993). Biodegradable Nanocapsules Containing a Lipophilic Immunomodulator: Drug Retention and Tolerance Towards MacrophagesIn Vitro. Journal of drug targeting. 1(2). 157–164. 12 indexed citations

15.

Barratt, Gillian, et al.. (1991). Anti-metastatic activity in vivo of MDP-l-alanyl-cholesterol (MTP-Chol) entrapped in nanocapsules. International Journal of Immunopharmacology. 13(2-3). 167–173. 13 indexed citations

16.

Devissaguet, J.P., et al.. (1991). Effect of multiple film coverage in sustained release pellets. Drug Development and Industrial Pharmacy. 17(1). 7–25. 8 indexed citations

17.

Ammoury, Nazih, Hatem Fessi, J.P. Devissaguet, F. Puisieux, & Simon Benita. (1990). In Vitro Release Kinetic Pattern of Indomethacin from Poly(D,L-Lactide) Nanocapsules. Journal of Pharmaceutical Sciences. 79(9). 763–767. 66 indexed citations

18.

Aprahamian, Marc, Christine Michel, W. Humbert, J.P. Devissaguet, & Christiane Damgé. (1987). Transmucosal passage of polyalkylcyanoacrylate nanocapsules as a new drug carrier in the small intestine. Biology of the Cell. 61(1-2). 69–76. 123 indexed citations

19.

Campbell, David B., et al.. (1986). Biodisposition of Tertatolol in Man: A Review. American Journal of Nephrology. 6(2). 61–68. 8 indexed citations

20.

Roblot-Treupel, L., et al.. (1986). Development of a new process for the manufacture of polyisobutylcyanoacrylate nanocapsules. International Journal of Pharmaceutics. 28(2-3). 125–132. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact